{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-176471","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.457911+00:00","generated_at":"2026-06-25T00:58:28.896285+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vor Biopharma stockholders elect three Class I directors and ratify E&Y as auditor","bullets":["Stockholders elected Matthew Patterson, Daniella Beckman, and Kush Parmar as Class I directors for terms until 2025.","Ratification of Ernst & Young LLP as independent auditor for FY2022: 28,763,851 votes for, 3,220 against, 2,428 abstain.","Approximately 76.69% of eligible shares were represented at the Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-176471","json":"https://secwatch.observer/filing/0001193125-22-176471.json","markdown":"https://secwatch.observer/filing/0001193125-22-176471.md","text":"https://secwatch.observer/filing/0001193125-22-176471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312522176471/0001193125-22-176471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312522176471/d220959d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:58:28.896285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}